| CD160 |
CD160, BY55: CD160 antigen precursor |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
2.762 |
Evidence |
|
| GRAP |
GRAP: GRB2-related adapter protein |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
2.762 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
LRFN3 |
LRFN3, UNQ5865/PRO34192: Leucine-rich repeat and fibronectin type-III domain-con |
2.762 |
Evidence |
|
| FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
2.762 |
Evidence |
|
| RANBP1 |
RANBP1: Ran-specific GTPase-activating protein |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
2.762 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
2.762 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
DOK1 |
DOK1: Docking protein 1 |
2.762 |
Evidence |
|
| FABP3 |
FABP3, FABP11, MDGI: Fatty acid-binding protein, heart |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
2.762 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
TAOK1 |
TAOK1, KIAA1361, MAP3K16: Serine/threonine-protein kinase TAO1 |
2.76 |
Evidence |
|
| CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
EEA1 |
EEA1, ZFYVE2: Early endosome antigen 1 |
2.76 |
Evidence |
|
| HCK |
IPI00029769 |
CAV1 |
CAV1, CAV: Caveolin-1 |
2.76 |
Evidence |
|
| TNNI3 |
TNNI3, TNNC1: Troponin I, cardiac muscle |
TNNI2 |
TNNI2: Troponin I, fast skeletal muscle |
2.76 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
2.76 |
Evidence |
|
| DCC |
DCC: Netrin receptor DCC precursor |
ROBO1 |
ROBO1, DUTT1: Roundabout homolog 1 precursor |
2.757 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
KCNJ12 |
KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 |
2.757 |
Evidence |
|
| MMP7 |
MMP7, MPSL1, PUMP1: Matrilysin precursor |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
2.757 |
Evidence |
|
| MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
SOS1 |
SOS1: Son of sevenless homolog 1 |
2.757 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
2.757 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
SCARB2 |
SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 |
2.757 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
ILK |
ILK, ILK1, ILK2: Integrin-linked protein kinase |
2.757 |
Evidence |
|
| MAP1B |
MAP1B: Microtubule-associated protein 1B |
K-ALPHA-1 |
TUBA1B: Tubulin alpha-1B chain |
2.757 |
Evidence |
|
| CRSP2 |
MED14, ARC150, CRSP2, CXorf4, DRIP150, EXLM1, RGR1, TRAP170: Mediator of RNA pol |
EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
2.757 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
DNM1 |
IPI00552861 |
2.757 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.757 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
DAXX |
DAXX, BING2, DAP6: Death domain-associated protein 6 |
2.757 |
Evidence |
|
- 
- 
-